PK Study of Ticagrelor in Children Aged less than 24 Months, with Sickle Cell Disease (HESTIA4)

Trial Identifier: D5136C00010
Sponsor: AstraZeneca
NCTID:: NCT03492931
Start Date: March 2018
Primary Completion Date: May 2019
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Arabic Translation
Dutch Translation
French Translation
Italian Translation
Kiswahili Translation
Spanish Translation
English Translation

Trial Locations

Country Location
Belgium Edegem, Belgium, 2650
Egypt Al Sharkeya, Egypt, 44519
Egypt Alexandria, Egypt, 21131
Egypt Cairo, Egypt, 11562
Ghana Accra, Ghana, 233
Ghana Ho, Ghana, 0
Ghana Kumasi, Ghana, 1934
Ghana Navrongo, Ghana, 0
Italy CATANIA, Italy, 95123
Italy Genova, Italy, 16100
Italy Perugia, Italy, 6132
Italy Verona, Italy, 37126
Kenya Kisumu, Kenya, 40100
Kenya Nairobi, Kenya, 00200
Kenya Nairobi, Kenya, 00100
Kenya Siaya, Kenya, 40600
Lebanon Beirut, Lebanon, 11-0236
Lebanon Tripoli, Lebanon, 1434
Spain Madrid, Spain, 28041
Spain Madrid, Spain, 28007
United Kingdom CARDIFF, United Kingdom, CF14 4XW
United Kingdom London, United Kingdom, SE1 7EH